Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sustained intravesical drug delivery using thermosensitive hydrogel.

Pradeep Tyagi1, Zhenhua Li, Michael Chancellor

  • 1Center for Pharmacogenetics, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, USA.

Pharmaceutical Research
|June 8, 2004
PubMed
Summary

This study developed a thermosensitive hydrogel for sustained intravesical drug delivery, significantly improving drug exposure in the bladder and demonstrating efficacy in a cystitis model.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unraveling the complexity of bladder-centric chronic pain by intravesical contrast enhanced MRI.

Continence (Amsterdam, Netherlands)·2025
Same author

Targeting tumor-associated microbiome: A new aspect of modulating tumor microenvironment for cancer therapy.

Advanced drug delivery reviews·2025
Same author

Correction: Treating Lower Urinary Tract Symptoms in Older Adults: Intravesical Options.

Drugs & aging·2024
Same author

Editorial: a legacy of excellence: celebrating 40 years of the Diokno-Lapides essay contest.

International urology and nephrology·2024
Same author

Dynamic Covalent Hydrogel as a Single-Dose Vaccine Adjuvant for Sustained Antigen Release and Significantly Elevated Humoral Immunity.

Advanced healthcare materials·2024
Same author

Underactive Bladder According to the European Association of Urology Guidelines.

European urology·2024

Area of Science:

  • Biomaterials Science
  • Drug Delivery Systems
  • Urology

Background:

  • Intravesical therapy offers localized drug delivery for bladder diseases, avoiding systemic side effects.
  • Conventional intravesical methods lack prolonged drug retention, limiting therapeutic efficacy.
  • Sustained drug release is crucial for effective treatment of chronic bladder conditions.

Purpose of the Study:

  • To develop a thermosensitive hydrogel for sustained intravesical drug delivery.
  • To overcome the limitation of rapid drug clearance in the bladder.
  • To evaluate the efficacy of a novel hydrogel-based drug delivery system for bladder diseases.

Main Methods:

  • Utilized a thermosensitive Poly(ethylene glycol)-Poly[lactic acid-co-glycolic acid]-Poly(ethylene glycol) (PEG-PLGA-PEG) hydrogel.

Related Experiment Videos

  • Administered fluorescein isothiocyanate (FITC) in hydrogel and solution form to rats to assess drug release kinetics.
  • Evaluated hydrogel efficacy using a cyclophosphamide-induced cystitis rat model with misoprostol as the therapeutic agent.

    • Main Results:

    • Hydrogel encapsulation demonstrated sustained release of FITC for up to 24 hours, unlike rapid clearance of free FITC.
    • Intravesical administration of misoprostol-loaded hydrogel significantly reduced urinary voiding frequency in cystitis model.
    • Histological analysis revealed preserved urothelial morphology with hydrogel treatment, contrasting with damage in control groups.

    Conclusions:

    • The PEG-PLGA-PEG thermosensitive hydrogel is a promising platform for sustained intravesical drug delivery.
    • This system effectively enhances drug retention and therapeutic outcomes for bladder conditions like cystitis.
    • The developed hydrogel represents a viable advancement in intravesical therapy.